Current funding
Our lab is currently supported by two Norwegian Research Council (NFR) projects and a large EU Innovative Health Initiative. We also run several smaller projects with academic, clinical and industry partners.
Running projects
The role of Blastocystis in inflammatory bowel disease
NFR 324516
We test whether Blastocystis is truly pathogenic by combining cohort studies (>5,000 participants), a 400-patient IBD trial, cancer immunotherapy–associated colitis, and controlled rat infections — to inform clinical guidance on when (or whether) to treat.
Mitochondrial glycolysis as a target in pathogenic stramenopiles
NFR 301170
Some pathogens run part of glycolysis inside mitochondria, implying a dedicated metabolite transporter. We aim to identify/characterise this transporter as a selective drug target and to clarify the evolution of energy metabolism.
PREDICTOM — AI-driven early screening for Alzheimer’s disease
EU IHI 101132356
Developing an at-home sampling and digital assessment platform with AI analysis across a large European cohort (>4,000 participants) to enable earlier diagnosis and intervention.
Other ongoing projects
- Reassessment of intestinal parasites: Prevalence, ecosystem role, and implications for faecal microbiota transplantation. — Forskningsmidler Stavanger Universitetssjukehus.
- Digitalisert Point of Care-Testing for økt samhandling og avlasting i helsetjenestene. — HelseCampus Stavanger - Intensjonssøknad om såkornmidler with NordicDX.
- Predicting patients at risk of adverse effects after immunotherapy, a machine learning and AI approach. — Folke Hermansens Fond.
Selected past projects
- PigStick - Diagnostic of bacterial-caused lameness in pigs. — Norwegian Research Council NFR program: Kommersialiseringsprosjekt with Validé.
- Identification of microbiome-associated mechanisms mediating anthocyanin-dependent cognitive improvement in a population at risk for dementia. — Leon Jarners Minnefond with Prof. Dag Aarsland (King's College London)
- Microbial eukaryotes in inflammatory bowel disease – a pilot study. — Forskningsmidler Stavanger Universitetssjukehus with Dr. Tore Grimstad (SUS).
- The oral microbiome and nitric oxide bioavailability across the human lifespan. — BBSRC Responsive Mode with Prof. Andrew Jones and Prof. Anni Vanhatalo (Exeter)
- Does the potential for AMR selection differ between common UK cattle grazing systems? — NERC AMR in the Real World Pump Priming Grants with Prof. Michael Lee and Dr. Jenni Dungait (Rothamsted Research)
- Gut health in European lobsters - the gut microbiome as a health marker in offshore sea cage culture. Joint project with Prof. Grant Stentiford and Dr. David Bass (Centre for Environment, Fisheries & Aquaculture Science (Cefas)) and Dr. Carly Daniels (National Lobster Hatchery).